Kalman Katalin, Németh-Cahalan Karin L, Froger Alexandrine, Hall James E
Department of Physiology and Biophysics, University of California, Irvine, CA 92697-4561, USA.
J Biol Chem. 2008 Jul 25;283(30):21278-83. doi: 10.1074/jbc.M801740200. Epub 2008 May 28.
In Xenopus oocytes, the water permeability of AQP0 (P(f)) increases with removal of external calcium, an effect that is mediated by cytoplasmic calmodulin (CaM) bound to the C terminus of AQP0. To investigate the effects of serine phosphorylation on CaM-mediated Ca(2+) regulation of P(f), we tested the effects of kinase activation, CaM inhibition, and a series of mutations in the C terminus CaM binding site. Calcium regulation of AQP0 P(f) manifests four distinct phenotypes: Group 1, with high P(f) upon removal of external Ca(2+) (wild-type, S229N, R233A, S235A, S235K, K238A, and R241E); Group 2, with high P(f) in elevated (5 mm) external Ca(2+) (S235D and R241A); Group 3, with high P(f) and no Ca(2+) regulation (S229D, S231N, S231D, S235N, and S235N/I236S); and Group 4, with low P(f) and no Ca(2+) regulation (protein kinase A and protein kinase C activators, S229D/S235D and S235N/I236S). Within each group, we tested whether CaM binding mediates the phenotype, as shown previously for wild-type AQP0. In the presence of calmidazolium, a CaM inhibitor, S235D showed high P(f) and no Ca(2+) regulation, suggesting that S235D still binds CaM. Contrarily, S229D showed a decrease in recruitment of CaM, suggesting that S229D is unable to bind CaM. Taken together, our results suggest a model in which CaM acts as an inhibitor of AQP0 P(f). CaM binding is associated with a low P(f) state, and a lack of CaM binding is associated with a high P(f) state. Pathological conditions of inappropriate phosphorylation or calcium/CaM regulation could induce P(f) changes contributing to the development of a cataract.
在非洲爪蟾卵母细胞中,水通道蛋白0(AQP0)的水通透性(Pf)会随着胞外钙的去除而增加,这一效应由结合在AQP0 C末端的胞质钙调蛋白(CaM)介导。为了研究丝氨酸磷酸化对CaM介导的Ca²⁺对Pf的调节作用,我们测试了激酶激活、CaM抑制以及C末端CaM结合位点一系列突变的影响。AQP0 Pf的钙调节表现出四种不同的表型:第1组,去除胞外Ca²⁺后具有高Pf(野生型、S229N、R233A、S235A、S235K、K238A和R241E);第2组,在胞外Ca²⁺升高(5 mM)时具有高Pf(S235D和R241A);第3组,具有高Pf且无Ca²⁺调节(S229D、S231N、S231D、S235N和S235N/I236S);第4组,具有低Pf且无Ca²⁺调节(蛋白激酶A和蛋白激酶C激活剂、S229D/S235D和S235N/I236S)。在每组中,我们测试了CaM结合是否介导了该表型,正如之前对野生型AQP0所显示的那样。在存在CaM抑制剂氯丙咪嗪的情况下,S235D表现出高Pf且无Ca²⁺调节,这表明S235D仍然结合CaM。相反,S229D显示CaM募集减少,这表明S229D无法结合CaM。综上所述,我们的结果提出了一个模型,其中CaM作为AQP0 Pf的抑制剂。CaM结合与低Pf状态相关,而缺乏CaM结合与高Pf状态相关。不适当的磷酸化或钙/CaM调节的病理状况可能会诱导Pf变化,从而导致白内障的发展。